In a note to clients on Sunday, Jefferies analyst Steven G. DeSanctis estimated that for 2025, the Sweet 16 would show an aggregate earnings increase of 21.5%, with a median increase of 15.8%. For the ...

Billionaire alternative investment manager Howard Marks has outlined areas of caution in the equity market in tackling the question of whether or not stocks are in a bubble. Marks in a client memo ...

Almost 25 years to the day, influential investor Howard Marks has revisited the memo that cemented his reputation when ...

U.S. stocks represented over 70% of the MSCI World Index, the highest percentage since 1970. Is it a bubble? Find out.

Explore the best ETFs to buy in 2025. Discover top picks across a variety of sectors with insights to help you diversify and ...

In the Orkney Islands, archaeologists close the chapter on a legendary excavation, capping two decades of remarkable ...

Among Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta Platforms, and Tesla, there's a phenomenal bargain hiding in plain ...

Microsoft stands out as a good value for 2025 and beyond. The stock isn't overpriced, sporting a 34.9 price-to-earnings (P/E) ...

There are concerns that when the Magnificent Seven's run breaks, share prices will be hit hard but investors are reluctant to ...

With yields on the 30-year Treasury bond at their highest level in a year, the so-called Magnificent Seven group's outstanding bonds are offering juicy returns to start the new year and may be a smart ...

Nvidia stock was looking to find its footing on Wednesday after economic data prompted a Big Tech selloff the previous day.

Positive results from clinical trials often give biotechnology companies a boost, but this one was big. Shares of Sana Biotechnology —a firm with a market capitalization of less than $400 million as ...